{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:31:32Z","timestamp":1748338292874},"reference-count":26,"publisher":"Biomedical Research Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2220\/biomedres.37.215","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T23:34:11Z","timestamp":1467243251000},"page":"215-220","source":"Crossref","is-referenced-by-count":5,"title":["&lt;b&gt;Steroid changes adipokine concentration in the blood and bone marrow &lt;\/b&gt;&lt;b&gt;fluid &lt;\/b&gt;"],"prefix":"10.2220","volume":"37","author":[{"given":"Tatsuya","family":"FUKUSHIMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"HOZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"TOMITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"YONEKURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"MIYATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"MIYAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"TAGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"GOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"TSUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"OSAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Alessi MC, Poggi M and Juhan-Vague I (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. <i>Curr Opin Lipidol <\/i><b>18<\/b>, 240-245.","DOI":"10.1097\/MOL.0b013e32814e6d29"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3 Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP, Ganz R, Frey FJ and Kohler HP (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. <i>Transplantation <\/i><b>74<\/b>, 1147-1152.","DOI":"10.1097\/00007890-200210270-00016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4 Fukui K, Kominami R, Shinohara H and Matsumoto T (2006) Glucocorticoid induces micro-fat embolism in the rabbit: a scanning electron microscopic study. <i>J Orthop Res <\/i><b>24<\/b>, 675-683.","DOI":"10.1002\/jor.20091"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5 Goto H, Osaki M, Fukushima T, Sakamoto K, Hozumi A, Baba H and Shindo H (2011) Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. <i>Biomed Res (Tokyo) <\/i><b>32<\/b>, 37-44.","DOI":"10.2220\/biomedres.32.37"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM (1995) Weight-reducing effects of the plasma protein encoded protein by the obese gene. <i>Science <\/i><b>269<\/b>, 543-546.","DOI":"10.1126\/science.7624777"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7 Halleux CM, Declerck PJ, Tran SL, Detry R and Brichard SM (1999) Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. <i>J Clin Endocrinol Metab <\/i><b>84<\/b>, 4097-4105.","DOI":"10.1210\/jc.84.11.4097"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Hozumi A, Osaki M, Goto H, Sakamoto K, Inokuchi S and Shindo H (2009) Bone marrow adipocyte support dexamethasone-induced osteoclast differentiation. <i>Biochem Biophys Res Commun <\/i><b>382<\/b>, 780-784.","DOI":"10.1016\/j.bbrc.2009.03.111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9 Hozumi A, Osaki M, Sakamoto K, Goto H, Fukushima T, Baba H and Shindo H (2010) Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocyte. <i>Biomed Res (Tokyo) <\/i><b>31<\/b>, 281-286.","DOI":"10.2220\/biomedres.31.281"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Ibrahim AA, Yahata T, Onizuka M, Dan T, Strihou CVYD, Miyata T and Ando K (2014) Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration. <i>Stem Cells <\/i><b>32<\/b>, 946-958.","DOI":"10.1002\/stem.1577"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Kang P, Shen B, Yang J and Pei F (2008) Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis inpatients with osteonecrosis of the femoral head. <i>Thromb Res <\/i><b>123<\/b>, 367-373.","DOI":"10.1016\/j.thromres.2008.04.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Kerachian MA, Seguin C and Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action. <i>J Steroid Biochem Mol Biol <\/i><b>114<\/b>, 121-128.","DOI":"10.1016\/j.jsbmb.2009.02.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13 Kitajima M, Shigematsu M, Ogawa K, Sugihara H and Hotokebuchi T (2007) Effects of glucocorticoid on adipocyte size in human bone marrow. <i>Med Mol Morphol <\/i><b>40<\/b>, 150-156.","DOI":"10.1007\/s00795-007-0367-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Lara-Castro C, Fu Y, Chung BH and Garvey WT (2007) Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. <i>Curr Opin Lipidol <\/i><b>18<\/b>, 263-270.","DOI":"10.1097\/MOL.0b013e32814a645f"},{"key":"14","unstructured":"15 Laug WE, Aebersold R, Jong A, Rideout W, Berqman BL and Baker J (1989) Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. <i>Thromb Haemost <\/i><b>61<\/b>, 517-521."},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Miyanishi K, Kamo Y, Ihara H, Naka T, Hirakawa M and Sugioka Y (2006) Risk factors for dysbaric osteonecrosis. <i>Rheumatology (Oxf) <\/i><b>45<\/b>, 855-858.","DOI":"10.1093\/rheumatology\/kel013"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y and Iwamoto Y (2002) Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. <i>Bone <\/i><b>30<\/b>, 185-190.","DOI":"10.1016\/S8756-3282(01)00663-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H and Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. <i>Biochem Biophys Res Commun <\/i><b>331<\/b>, 520-526.","DOI":"10.1016\/j.bbrc.2005.03.210"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO and Drevon C (2001) Leptin isexpressed in and secreted from primary cultures of humanosteoblasts and promotes bone mineralization. <i>J Bone Miner Res <\/i><b>16<\/b>, 1426-1433.","DOI":"10.1359\/jbmr.2001.16.8.1426"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y and Funahashi T (2004) Adiponectin as a biomarker of the metabolic syndrome. <i>Circ J <\/i><b>68<\/b>, 975-981.","DOI":"10.1253\/circj.68.975"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Sakamoto K, Osaki M, Hozumi A, Goto H, Fukushima T, Baba H and Shindo H (2011) Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes. <i>BMC Musculoskelet Disord <\/i><b>12<\/b>, 82.","DOI":"10.1186\/1471-2474-12-82"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Mirua M, Fukuda Y, Takemura K, Tokunaga K and Matsuzawa Y (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. <i>Nat Med <\/i><b>2<\/b>, 800-803.","DOI":"10.1038\/nm0796-800"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Sprengers ED and Kluft C (1987) Plasminogen activator inhibitors. <i>Blood <\/i><b>69<\/b>, 381-387.","DOI":"10.1182\/blood.V69.2.381.381"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Suganami E, Takagi H, Ohasi H, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y and Yoshimura N (2004) Leptin stimulates ischemiainduced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. <i>Diabetes <\/i><b>53<\/b>, 2443-2448.","DOI":"10.2337\/diabetes.53.9.2443"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Tan X, Cai D, Wu Y, Liu B, Rong L, Chen Z and Zhao Q (2006) Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. <i>Transl Res <\/i><b>148<\/b>, 114-119.","DOI":"10.1016\/j.trsl.2006.05.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"27 Weinstein RS (2012) Glucocorticoid-induced osteonecrosis. <i>Endocrine <\/i><b>41<\/b>, 183-190.","DOI":"10.1007\/s12020-011-9580-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"29 Zizic TM, Marcoux C, Hungerford DS and Stevens MB (1986) The early diagnosis of ischemic necrosis of bone. <i>Arthritis Rheum <\/i><b>29<\/b>, 1177-1186.","DOI":"10.1002\/art.1780291001"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/37\/3\/37_215\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T04:03:35Z","timestamp":1600833815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/37\/3\/37_215\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.37.215","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}